U.S. High Court Won’t Review Medical Device Off-Label Preemption Debate

(January 12, 2016, 8:31 AM EST) -- WASHINGTON, D.C. — The U.S. Supreme Court on Jan. 11 declined to decide if its medical device preemption precedents preempt claims involving the off-label use of the Infuse bone graft (Patricia...
To view the full article, register now.